| Christian Klemt |
Christian Klemt is currently the Chief Financial Officer at uniQure NV since 2021. Prior to this, he worked as the Finance Director & Country Manager at CGG from 2009 to 2015. He also served as the Manager-Group Finance at LyondellBasell Industries NV from 2005 to 2007. Mr. Klemt holds an MBA from the University of Münster. |
| Robert Gut |
Robert Gut is currently a Non-Executive Director at uniQure NV. Previously, he held positions as Vice President-Medical Affairs & Development at Radius Health, Inc. and VP-Clinical Development & Medical Affairs at Novo Nordisk, Inc. He also served as the Chief Medical Officer, Head-Clinical & Medical at Versartis, Inc. from 2017 to 2018. Dr. Gut obtained a doctorate degree from the Medical University of Lublin. |
| Carla Poulson |
Carla Poulson is currently the Chief People & Culture Officer at uniQure NV. Previously, she held positions as the Director of Human Resources at Vertex Pharmaceuticals, Inc., the Chief People Officer & Senior Vice President at Mersana Therapeutics, Inc., and the Chief Human Resources Officer & Senior VP at Akcea Therapeutics, Inc. Ms. Poulson obtained her undergraduate and graduate degrees from the University of Illinois. |
| Jeannette Potts |
Jeannette Potts is currently the Secretary, Senior Vice President & General Counsel at Forma Therapeutics Holdings, Inc. and also holds the position of Chief Legal & Compliance Officer at uniQure NV. Previously, she worked as the Director-Marketing & Sales at Viroblock SA and as the Associate General Counsel at Millennium Pharmaceuticals, Inc. She was also the VP, Head Counsel-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. from 2013 to 2019. Dr. Potts holds a doctorate degree from the University of Virginia, an undergraduate degree from Smith College, a graduate degree from Suffolk University, and an undergraduate degree from Trinity College Dublin. |
| Richard Porter |
Richard Porter is the founder of uniQure France SAS, which was founded in 2019. He held the title of Chief Executive Officer & Director at uniQure France SAS. Currently, Dr. Porter is the Chief Business & Scientific Officer at uniQure NV, starting in 2021. Dr. Porter's former positions include General Manager-Product at Shire Plc from 2011 to 2014, Global Head-Scientific Business Strategy at Roche Group from 2014 to 2016, and Chief Operating Officer at Therachon AG from 2016 to 2019. Dr. Porter obtained a doctorate degree from The University of Southampton. |
| Erin Boyer |
Erin Boyer is currently the Chief People & Culture Officer at uniQure NV since 2022. Previously, she worked as the Head-Global Talent Strategy & Planning at Alnylam Pharmaceuticals, Inc., Chief People & Culture Officer at Epizyme, Inc., and Vice President-Human Resources at Obsidian Therapeutics, Inc. Ms. Boyer completed her undergraduate degree at Macalester College. |
| Pierre Caloz |
Pierre Caloz is currently the Chief Operating Officer at uniQure NV since 2021. Prior to this, he worked as the SVP, GM-European Union & Asia Pacific Operations at CSL Behring NV. Caloz completed his undergraduate degree from the University of Geneva in 1996, followed by a graduate degree from the Swiss Federal Institute of Technology in 1997. He also holds an MBA from Ashridge Business School, which he completed in 2010. |
| Walid Abi-Saab |
Walid Abi-Saab is currently the Chief Medical Officer at uniQure NV since 2023. Prior to this, he worked as the Chief Medical Officer at Galapagos NV from 2017 to 2022. He also held positions as Group Vice President-Clinical Development at Shire Plc, Assistant Professor-Psychiatry & Neurosurgery at Yale School of Medicine, and Group Vice President at Shire International GmbH (Switzerland). Abi-Saab received his undergraduate degree from the American University of Beirut and his doctorate from Université Saint-Joseph. |
| Maria E. Cantor |
Maria E. Cantor is currently the Chief Corporate Affairs Officer at uniQure NV. Previously, she worked as the Senior Director-Corporate Communications at Genzyme Corp. from 2001 to 2008. Before that, she was the Director-Public Relations & Marketing at St. Elizabeth's Medical Center from 2000 to 2001. Maria also served as the Director-Marketing & Communications at SunLink ScriptsRx LLC and Optima Healthcare, Inc. from 1994 to 2000. Additionally, she held the position of SVP-Corporate Affairs & Head-Investor Relations at ARIAD Pharmaceuticals, Inc. Ms. Cantor completed her undergraduate degree at Emerson College and her graduate degree at S.I. Newhouse School of Public Communications. |
| Matthew C. Kapusta |
Matthew C. Kapusta is currently the Chief Executive Officer & Executive Director at uniQure NV since 2015. He previously served as an Independent Director at Decibel Therapeutics, Inc. in 2023. Before that, he held positions as Vice President-Finance & Strategic Planning at Smith & Nephew plc, MD-Healthcare Investment Banking at Collins Stewart, Inc., and Senior Vice President-Business Development at AngioDynamics, Inc. from 2011 to 2014. He also worked as Vice President-Finance at Smith & Nephew Orthopaedics Ltd. Mr. Kapusta completed his undergraduate degree at Stephen M. Ross School of Business and earned an MBA from The Leonard N Stern School of Business. |
| David D. Meek |
David D. Meek is currently the Non-Executive Chairman at uniQure NV since 2021, Chairman at Entasis Therapeutics, Inc. since 2019, Chairman at Entasis Therapeutics Holdings, Inc. since 2019, Director at the European Federation of Pharmaceutical Industries & Assns, Director at Fusion Pharmaceuticals, Inc. starting in 2023, and Director at the Camping & Education Foundation. Previously, he served as the Chief Executive Officer & Director at Ipsen SA from 2016 to 2019, Chief Executive Officer & Director at Mirati Therapeutics, Inc. from 2021 to 2023, President & Chief Executive Officer at Novartis Pharmaceuticals Canada, Inc. from 2005 to 2012, Chief Executive Officer at Ipsen Manufacturing Ireland Ltd., President, Chief Executive Officer & Director at FerGene, Inc. from 2020 to 2021, Chairman at Ipsen Pharma SAS, Director at the Pharmaceutical Research & Manufacturers of America, Director at Stargazer Pharmaceuticals, Inc., Head-Global Franchise at Novartis International AG from 2005 to 2012, Executive Vice President & President-Oncology at Baxalta, Inc. from 2014 to 2016, and Chief Commercial Officer at Endocyte, Inc. from 2012 to 2014. He obtained his undergraduate degree from the University of Cincinnati (Ohio). |
| Amin Abujoub |
Amin Abujoub is currently working as the Chief Quality Officer at uniQure NV. Previously, he held the position of Senior Vice President-Global Quality at Intercept Pharmaceuticals, Inc. Dr. Abujoub has an undergraduate degree and a doctorate from American University. |
| Jacques Rachelle Suzanne |
Jacques Rachelle Suzanne is currently the President, Chief Executive Officer & Director at Akari Therapeutics Plc, a Director at Corbus Pharmaceuticals, Inc., an Independent Non-Executive Director at uniQure NV, a Trustee at Alma College, and a Member-Equality Task Force at Alliance for Regenerative Medicine. Previously, Ms. Suzanne served as the Chief Executive Officer at Enzyvant, Inc., the Chief Executive Officer at Enzyvant Therapeutics, Inc., a Director at Viela Bio, Inc., a Vice President-Business Operations at Baxter International, Inc., a Senior Vice President-Global Complement Franchise at Alexion Pharmaceuticals, Inc., a Vice President-Hematology Marketing at Shire Plc, a Vice President-Business Operations at Baxalta, Inc., and worked as a Financial Auditor at Ernst & Young LLP and Deloitte & Touche LLP. Ms. Suzanne obtained an undergraduate degree from Alma College. |
